Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
…, JI Herschkowitz, C Fan, X Zhang… - Proceedings of the …, 2009 - National Acad Sciences
Some breast cancers have been shown to contain a small fraction of cells characterized by
CD44 + /CD24 −/low cell-surface antigen profile that have high tumor-initiating potential. In …
CD44 + /CD24 −/low cell-surface antigen profile that have high tumor-initiating potential. In …
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and …
…, D Wilkie, A McNabola, H Rong, C Chen, X Zhang… - Cancer research, 2004 - AACR
The RAS/RAF signaling pathway is an important mediator of tumor cell proliferation and
angiogenesis. The novel bi-aryl urea BAY 43-9006 is a potent inhibitor of Raf-1, a member of the …
angiogenesis. The novel bi-aryl urea BAY 43-9006 is a potent inhibitor of Raf-1, a member of the …
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
…, SG Hilsenbeck, A Pavlick, X Zhang… - Journal of the …, 2008 - academic.oup.com
Background Tumorigenic breast cancer cells that express high levels of CD44 and low or
undetectable levels of CD24 (CD44 > /CD24 >/low ) may be resistant to chemotherapy and …
undetectable levels of CD24 (CD44 > /CD24 >/low ) may be resistant to chemotherapy and …
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models
X Zhang, S Claerhout, A Prat, LE Dobrolecki, I Petrovic… - Cancer research, 2013 - AACR
Breast cancer research is hampered by difficulties in obtaining and studying primary human
breast tissue, and by the lack of in vivo preclinical models that reflect patient tumor biology …
breast tissue, and by the lack of in vivo preclinical models that reflect patient tumor biology …
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Eradicating triple-negative breast cancer (TNBC) resistant to neoadjuvant chemotherapy (NACT)
is a critical unmet clinical need. In this study, patient-derived xenograft (PDX) models of …
is a critical unmet clinical need. In this study, patient-derived xenograft (PDX) models of …
[HTML][HTML] Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells
Introduction Normal and malignant breast tissue contains a rare population of multi-potent
cells with the capacity to self-renew, referred to as stem cells, or tumor initiating cells (TIC). …
cells with the capacity to self-renew, referred to as stem cells, or tumor initiating cells (TIC). …
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
L Liu, Y Cao, C Chen, X Zhang, A McNabola, D Wilkie… - Cancer research, 2006 - AACR
Angiogenesis and signaling through the RAF/mitogen-activated protein/extracellular signal-regulated
kinase (ERK) kinase (MEK)/ERK cascade have been reported to play important …
kinase (ERK) kinase (MEK)/ERK cascade have been reported to play important …
Extracellular histones are major mediators of death in sepsis
J Xu, X Zhang, R Pelayo, M Monestier, CT Ammollo… - Nature medicine, 2009 - nature.com
Hyperinflammatory responses can lead to a variety of diseases, including sepsis 1 . We now
report that extracellular histones released in response to inflammatory challenge contribute …
report that extracellular histones released in response to inflammatory challenge contribute …
A presynaptic inositol-5-phosphatase
…, EP Garcia, VI Slepnev, C David, X Zhang… - Nature, 1996 - nature.com
SYNAPTOJANIN is a nerve terminal protein of relative molecular mass 145,000 which
appears to participate with dynamin in synaptic vesicle recycling 1,2 . The central region of …
appears to participate with dynamin in synaptic vesicle recycling 1,2 . The central region of …
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells
…, S Huang, M Chamorro, X Zhang… - Proceedings of the …, 2003 - National Acad Sciences
Breast cancer is a genetically and clinically heterogeneous disease, and the contributions
of different target cells and different oncogenic mutations to this heterogeneity are not well …
of different target cells and different oncogenic mutations to this heterogeneity are not well …